BioSphere® PUTTY
Bone grafting
ApprovedActive
Key Facts
About Synergy Biomedical
Synergy Biomedical is a commercial-stage medical device company focused on advancing bone healing through its proprietary bioactive glass technology. The company's BioSphere® product portfolio, including putties and delivery systems, is designed as a synthetic alternative to autografts and allografts, targeting the orthopedic bone graft substitute market. Led by an experienced management team with deep orthopedic industry backgrounds, Synergy has successfully launched multiple products and appears to be in a revenue-generating phase. Its strategy centers on product line extensions and leveraging the unique material properties of its engineered spherical bioactive glass particles.
View full company profileTherapeutic Areas
Other Bone grafting Drugs
| Drug | Company | Phase |
|---|---|---|
| OsteoAMP / AlloFuse | Bioventus | Commercial |
| DBLogix / CeLLogix | Omnia Medical | Commercial |
| ALLOCYTE® Plus Advanced Viable Bone Matrix | Sanara MedTech | Approved/Commercial |
| ACTIGEN™ Verified Inductive Bone Matrix | Sanara MedTech | Approved/Commercial |